Dietary weight management may boost fertility-sparing cancer treatment outcomes
NCT ID NCT06169449
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a calorie-controlled diet can improve tumor outcomes and metabolic health in overweight or obese women with endometrial cancer who are undergoing fertility-sparing treatment. 240 participants will be randomly assigned to either a structured weight management program or routine care. Researchers will track body measurements, blood markers, and cancer remission rates to see if weight loss makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
weight management (diet)
What this could lead to
If it works, this could show that a structured diet helps control endometrial cancer while preserving fertility, offering a safer option for overweight patients.
What could go wrong
This is a behavioral intervention, not a drug, so results may vary widely. The study is early and focuses on weight-related markers, not long-term cancer survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIUM CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, China, 100044, China
Contact Phone: •••-•••-••••